Global Information
회사소개 | 문의 | 비교리스트

세계의 심혈관 문합기 시장 예측(-2027년) : 제품 유형별(자동, 수동), 최종 용도별, 지역별 - COVID-19의 누적 영향

Cardiovascular Anastomosis Devices Market Research Report by Product Type (Automatic and Manual), End-Use, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2022년 06월 상품코드 1089760
페이지 정보 영문 190 Pages 배송안내 1-2일 (영업일 기준)
가격
US $ 3,949 ₩ 5,141,000 Online Access (Single User License - 1 Year)
US $ 4,949 ₩ 6,443,000 PDF (Single User License) + Excel
US $ 5,949 ₩ 7,745,000 PDF (1-5 User License) + Excel
US $ 7,949 ₩ 10,349,000 PDF (Site License) + Excel
US $ 9,949 ₩ 12,953,000 PDF (Enterprise User License) + Excel


세계의 심혈관 문합기 시장 예측(-2027년) : 제품 유형별(자동, 수동), 최종 용도별, 지역별 - COVID-19의 누적 영향 Cardiovascular Anastomosis Devices Market Research Report by Product Type (Automatic and Manual), End-Use, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19
발행일 : 2022년 06월 페이지 정보 : 영문 190 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 심혈관 문합기 시장 규모는 2027년까지 26억 5,500만 달러에 이르고, 연평균 복합 성장률(CAGR) 10.21%의 성장이 예측됩니다

세계의 심혈관 문합기(Cardiovascular Anastomosis Devices) 시장에 대해 조사했으며, 시장 기회와 과제, 성장 촉진요인 및 억제요인, COVID-19의 누적 영향, 제품 유형별/최종 용도별/지역별 시장 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 제공합니다.

목차

제1장 서문

제2장 조사 방법

제3장 개요

제4장 시장 개요

제5장 시장 인사이트

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제
  • COVID-19의 누적 영향

제6장 심혈관 문합기 시장 : 제품 유형별

  • 자동
  • 수동

제7장 심혈관 문합기 시장 : 최종 용도별

  • 외래수술센터(ASC)
  • 병원
  • 전문 클리닉

제8장 아메리카의 심혈관 문합기 시장

  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

제9장 아시아태평양의 심혈관 문합기 시장

  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 싱가포르
  • 한국
  • 대만
  • 태국

제10장 유럽, 중동 및 아프리카의 심혈관 문합 장비 시장

  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트(UAE)
  • 영국

제11장 경쟁 구도

  • FPNV 포지셔닝 매트릭스
    • 상한
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 시장 점유율 분석 : 주요 기업별
  • 경쟁 시나리오
    • 인수합병(M&A)
    • 합의/협업/파트너십
    • 신제품 출시 및 개선
    • 투자 및 펀딩
    • 수상/인정/확장

제12장 기업 개요

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Becton Dickinson Holdings Pte Ltd
  • Biosintex
  • Boston Scientific Corporation
  • CONMED Corporation
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Getinge AB
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services, Inc.
  • LivaNova PLC
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Smith & Nephew plc
  • Vitalitec International GmbH

제13장 부록

LSH 22.06.23

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET: DYNAMICS
  • FIGURE 2. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (%)
  • FIGURE 3. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (USD MILLION)
  • FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2027
  • FIGURE 5. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATIC, 2019-2027 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATIC, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 7. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, 2019-2027 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 9. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2021 VS 2027 (%)
  • FIGURE 10. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2021 VS 2027 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2027
  • FIGURE 12. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2019-2027 (USD MILLION)
  • FIGURE 13. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 14. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
  • FIGURE 15. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 16. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2019-2027 (USD MILLION)
  • FIGURE 17. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 18. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 19. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 20. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 21. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 22. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 23. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 25. AUSTRALIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 26. CHINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 27. INDIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 28. INDONESIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 29. JAPAN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 30. MALAYSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 31. PHILIPPINES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 32. SINGAPORE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 33. SOUTH KOREA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 34. TAIWAN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 35. THAILAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 36. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 37. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 38. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 39. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 40. NETHERLANDS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 41. QATAR CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 42. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 43. SAUDI ARABIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 44. SOUTH AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 45. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 46. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 47. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 48. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET: FPNV POSITIONING MATRIX
  • FIGURE 49. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET: SHARE, BY KEY PLAYER, 2021
  • FIGURE 50. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET: SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATIC, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 5. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATIC, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 6. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATIC, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 7. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATIC, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 8. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATIC, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 10. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 11. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 12. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 13. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 14. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
  • TABLE 15. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 16. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 17. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 18. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 20. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 21. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 22. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 23. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 24. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 25. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 26. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 27. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 29. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 30. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 31. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 32. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 33. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 34. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 35. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 37. AUSTRALIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 38. CHINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 39. INDIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 40. INDONESIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 41. JAPAN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 42. MALAYSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 43. PHILIPPINES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 44. SINGAPORE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 45. SOUTH KOREA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 46. TAIWAN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 47. THAILAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 48. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 49. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 50. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 51. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 52. NETHERLANDS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 53. QATAR CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 54. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 55. SAUDI ARABIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 56. SOUTH AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 57. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 58. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 59. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 60. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET: SCORES
  • TABLE 61. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET: BUSINESS STRATEGY
  • TABLE 62. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET: PRODUCT SATISFACTION
  • TABLE 63. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET: RANKING
  • TABLE 64. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET: SHARE, BY KEY PLAYER, 2021
  • TABLE 65. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET: MERGER & ACQUISITION
  • TABLE 66. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 67. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 68. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET: INVESTMENT & FUNDING
  • TABLE 69. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 70. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET: LICENSE & PRICING

The Global Cardiovascular Anastomosis Devices Market grew USD 2,655.00 million by 2027, at a CAGR of 10.21%.

The Global Cardiovascular Anastomosis Devices Market size was estimated at USD 1,481.23 million in 2021 and expected to reach USD 1,628.76 million in 2022, and is projected to grow at a CAGR 10.21% to reach USD 2,655.00 million by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Cardiovascular Anastomosis Devices to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product Type, the market was studied across Automatic and Manual.

Based on End-Use, the market was studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cardiovascular Anastomosis Devices market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cardiovascular Anastomosis Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cardiovascular Anastomosis Devices Market, including Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Becton Dickinson Holdings Pte Ltd, Biosintex, Boston Scientific Corporation, CONMED Corporation, CryoLife, Inc., Edwards Lifesciences Corporation, Getinge AB, Intuitive Surgical, Inc., Johnson & Johnson Services, Inc., LivaNova PLC, Medtronic plc, Meril Life Sciences Pvt. Ltd., Smith & Nephew plc, and Vitalitec International GmbH.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Cardiovascular Anastomosis Devices Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cardiovascular Anastomosis Devices Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cardiovascular Anastomosis Devices Market?
  • 4. What is the competitive strategic window for opportunities in the Global Cardiovascular Anastomosis Devices Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Cardiovascular Anastomosis Devices Market?
  • 6. What is the market share of the leading vendors in the Global Cardiovascular Anastomosis Devices Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Cardiovascular Anastomosis Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cardiac diseases globally
      • 5.1.1.2. Rising sedentary lifestyle along with increasing smoking, tobacco, and alcohol consumption
      • 5.1.1.3. Growing number of surgical procedures globally
    • 5.1.2. Restraints
      • 5.1.2.1. Highly expensive treatments and lack of advanced healthcare infrastructure
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in technological developments in the cardiovascular anastomosis devices
      • 5.1.3.2. Government initiatives and availability of funding for healthcare facilities
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns related to anastomosis complications
  • 5.2. Cumulative Impact of COVID-19

6. Cardiovascular Anastomosis Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Automatic
  • 6.3. Manual

7. Cardiovascular Anastomosis Devices Market, by End-Use

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals
  • 7.4. Specialty Clinics

8. Americas Cardiovascular Anastomosis Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cardiovascular Anastomosis Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand

10. Europe, Middle East & Africa Cardiovascular Anastomosis Devices Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Competitive Scenario
    • 11.4.1. Merger & Acquisition
    • 11.4.2. Agreement, Collaboration, & Partnership
    • 11.4.3. New Product Launch & Enhancement
    • 11.4.4. Investment & Funding
    • 11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories
  • 12.2. B. Braun Melsungen AG
  • 12.3. Baxter International, Inc.
  • 12.4. Becton Dickinson Holdings Pte Ltd
  • 12.5. Biosintex
  • 12.6. Boston Scientific Corporation
  • 12.7. CONMED Corporation
  • 12.8. CryoLife, Inc.
  • 12.9. Edwards Lifesciences Corporation
  • 12.10. Getinge AB
  • 12.11. Intuitive Surgical, Inc.
  • 12.12. Johnson & Johnson Services, Inc.
  • 12.13. LivaNova PLC
  • 12.14. Medtronic plc
  • 12.15. Meril Life Sciences Pvt. Ltd.
  • 12.16. Smith & Nephew plc
  • 12.17. Vitalitec International GmbH

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
Back to Top
전화 문의
F A Q